Research Unit of Biomedicine/Pharmacology and Toxicology and Medical Research Center Oulu, University of Oulu, Aapistie 5 B, Oulu, 90014, Finland.
Division for Risk Assessment and Nutrition, National Food Institute, Technical University of Denmark, Lyngby, Denmark.
Arch Toxicol. 2019 Jun;93(6):1779-1788. doi: 10.1007/s00204-019-02467-w. Epub 2019 May 3.
Toxicological risk assessment of plant protection products (PPP) is currently carried out with the principal input from regulatory toxicology studies following OECD test guidelines, with little input from epidemiological data. An EFSA-commissioned systematic review of pesticide epidemiological studies (Ntzani et al. in Literature review on epidemiological studies linking exposure to pesticides and health effects. EFSA supporting publication 2013:EN-497, 2013) revealed statistically significant associations, among others, between pesticide exposures, and Parkinson's disease and childhood leukemia. Thereafter, EFSA launched a project with a mandate for the plant protection products and their residues (PPR) Panel to set the ground for the use of epidemiological data in the risk assessment of pesticides, as requested by Regulation (EC) 1107/2009. The project culminated with the publication of two EFSA's scientific opinions on the potential contribution of experimental investigations and epidemiological studies in PPP risk assessment and with the scientific conference held on 20 November 2017, in Parma, Italy. The application of modern methodologies in exposure assessment, toxicology and epidemiology would improve the pesticide risk assessment process and support a mechanistic shift for the integration of these three disciplines under a novel paradigm in risk assessment. The application of the adverse outcome pathway (AOP) conceptual framework to this approach would contribute to gain insight into the biological plausibility of a hazard identified in epidemiological or experimental studies and would inform an Integrated Approach to Testing and Assessment (IATA) within a regulatory context.
目前,植物保护产品(PPP)的毒理学风险评估主要是根据经合组织测试指南的监管毒理学研究结果进行的,很少有流行病学数据的输入。根据 EFSA 的委托,对农药流行病学研究进行了系统审查(Ntzani 等人在将暴露于农药与健康影响相关联的流行病学研究文献综述中。EFSA 支持出版物 2013:EN-497,2013 年),除其他外,发现农药暴露与帕金森病和儿童白血病之间存在统计学上显著的关联。此后,EFSA 启动了一个项目,委托植物保护产品及其残留物(PPR)小组为在农药风险评估中使用流行病学数据奠定基础,这是根据法规(EC)1107/2009 的要求进行的。该项目的最终成果是发表了两份 EFSA 的科学意见,即实验研究和流行病学研究在 PPP 风险评估中的潜在贡献,以及 2017 年 11 月 20 日在意大利帕尔马举行的科学会议。在暴露评估、毒理学和流行病学中应用现代方法将改进农药风险评估过程,并支持在风险评估的新范式下整合这三个学科的机制转变。将不良结局途径(AOP)概念框架应用于这种方法将有助于深入了解在流行病学或实验研究中确定的危害的生物学合理性,并将为监管背景下的综合测试和评估方法(IATA)提供信息。